Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 6 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Grifols Worldwide Operations Limited is currently managing 8 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 8 pending office actions are distributed among 7 distinct examiners, indicating that almost every case is handled by a different individual. Furthermore, these examiners are spread across 6 distinct art units, which suggests a broad range of technical sub-fields within the portfolio.
The busiest examiner for this company is DABKOWSKI, ERINNE R, who is currently responsible for 2 busiest examiner pending office actions. The remaining 6 pending office actions are split among the other 6 distinct examiners. This distribution across 6 distinct art units requires practitioners to be familiar with a variety of examination practices within Biotechnology & Pharmaceuticals.
With 8 pending office actions and 7 distinct examiners, the portfolio is decentralized. DABKOWSKI, ERINNE R holds the highest concentration of work with 2 busiest examiner pending office actions, but the majority of the 8 pending office actions are handled individually. Managing this volume across 6 distinct art units requires a coordinated effort to ensure consistency in prosecution strategy.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (25%) |
| §102 only | 1 (12%) |
| Double-patenting + other | 5 (62%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DABKOWSKI, ERINNE R | 2 | 55.9% | +69.0% |
| REYNOLDS, FRED H | 1 | 33.0% | +39.2% |
| D' AMBROSIO, THEA | 1 | 55.3% | +56.1% |
| CHEONG, CHEOM-GIL | 1 | 64.2% | +52.6% |
| YAO, LEI | 1 | 59.7% | +65.3% |
| BALLARD, KIMBERLY | 1 | 53.7% | +49.0% |
| MENON, KRISHNAN S | 1 | 59.7% | +11.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000380 | HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR | YAO, LEI | 78d |
| 17809524 | IN VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID | BALLARD, KIMBERLY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18004233 | COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS | D' AMBROSIO, THEA | 25d overdue |
| 18002245 | METHOD FOR OBTAINING A COMPOSITION COMPRISING HUMAN PLASMA-DERIVED IMMUNOGLOBULIN M | CHEONG, CHEOM-GIL | 10d overdue |
| 18543196 | USE OF LOW VOLUME PLASMA EXCHANGE FOR TREATING THE EARLY AND MIDDLE STAGES OF ALZHEIMER'S DISEASE | DABKOWSKI, ERINNE R | 7d |
| 18548545 | ALPHA-1 ANTITRYPSIN DOSING REGIMEN | REYNOLDS, FRED H | 60d |
| 18004231 | COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS | DABKOWSKI, ERINNE R | 75d |
| 18000380 | HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR | YAO, LEI | 78d |
| 17809524 | IN VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID | BALLARD, KIMBERLY | — |
| 17631819 | METHOD FOR CONTROLLING THE AMOUNT OF ANTICOAGULANT PRESENT IN COLLECTED PLASMA AFTER APHERESIS | MENON, KRISHNAN S | — |
| Art Unit | Apps |
|---|---|
| 1654 | 3 |
| 1658 | 1 |
| 1645 | 1 |
| 1642 | 1 |
| 1649 | 1 |
| 1777 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18543196 | USE OF LOW VOLUME PLASMA EXCHANGE FOR TREATING THE EARLY AND MIDDLE STAGES OF ALZHEIMER'S DISEASE | DABKOWSKI, ERINNE R | 1654 | §102DP | Final Rejection | 7d | Pending | Dec 18, 2023 |
| 18548545 | ALPHA-1 ANTITRYPSIN DOSING REGIMEN | REYNOLDS, FRED H | 1658 | §103§112DPOther | Non-Final OA | 60d | Pending | Aug 31, 2023 |
| 18004231 | COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS | DABKOWSKI, ERINNE R | 1654 | §102DPOther | Non-Final OA | 75d | Pending | Jan 04, 2023 |
| 18004233 | COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS | D' AMBROSIO, THEA | 1654 | §102§103§112DP | Final Rejection | 25d overdue | Pending | Jan 04, 2023 |
| 18002245 | METHOD FOR OBTAINING A COMPOSITION COMPRISING HUMAN PLASMA-DERIVED IMMUNOGLOBULIN M | CHEONG, CHEOM-GIL | 1645 | §112DP | Non-Final OA | 10d overdue | Pending | Dec 16, 2022 |
| 18000380 | HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR | YAO, LEI | 1642 | §101§102§103 | Non-Final OA | 78d | Pending | Nov 30, 2022 |
| 17809524 | IN VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID | BALLARD, KIMBERLY | 1649 | §101§102§112 | Non-Final OA | — | Pending | Jun 28, 2022 |
| 17631819 | METHOD FOR CONTROLLING THE AMOUNT OF ANTICOAGULANT PRESENT IN COLLECTED PLASMA AFTER APHERESIS | MENON, KRISHNAN S | 1777 | §102 | Final Rejection | — | Pending | Jan 31, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial